| Particulars |
| Company Name |
Sanofi India Ltd |
Year End |
202412 |
| Full Year |
| Equity (Rs Cr.) |
23.03 |
B.V. Rs |
339.60 |
| Sales Rs Cr. |
2,013.20 |
NP Rs Cr. |
442.27 |
| NP Var% |
-25.00 |
Div% |
1,170.00 |
| CPS Rs |
208.00 |
EPS Rs |
192.00 |
| Traded Value(Rs Lakhs) |
49.17 |
52 Week High |
6,718.00 |
| 52 Week Low |
4,017.00 |
Price BSE |
4,159.00 |
| Price NSE |
4,164.00 |
Market Capital(Rs Cr.) |
9,577.26 |
| P/C Ratio |
20.00 |
P/E Ratio |
21.70 |
| Price Vs.BV |
12.25 |
|
| Latest Quarter |
| Year End |
202509 |
Sales Rs Cr. |
475.40 |
| NP Rs Cr. |
94.97 |
NP Var % |
16.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
2,192.20 |
| OPM |
24.34 |
NP |
421.55 |
| NP Var% |
4.45 |
EPS |
160.35 |
| PE |
25.93 |
|
|